Have a personal or library account? Click to login
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities Cover

Authors

Giulia Negro

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium

Bertram Aschenbrenner

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium

Simona Kranjc Brezar

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Maja Cemazar

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
University of Primorska, Faculty of Health Sciences, Izola, Slovenia
EORTC PathoBiology Group, Brussels, Belgium

Andrej Coer

University of Primorska, Faculty of Health Sciences, Izola, Slovenia
Orthopaedic Hospital Valdoltra, Ankaran, Slovenia

Gorana Gasljevic

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Dragana Savic

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium

Maxim Sorokin

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Omicsway Corp, Walnut, USA
EORTC PathoBiology Group, Brussels, Belgium

Anton Buzdin

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Oncobox ltd, Moscow, Russia
EORTC PathoBiology Group, Brussels, Belgium

Maurizio Callari

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
EORTC PathoBiology Group, Brussels, Belgium

Irma Kvitsaridze

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium

Anahid Jewett

Division of Oral Biology and Medicine Microbiology, Immunology, & Molecular Genetics, Tumor Immunology Laboratory, College of Letters & Science, UCLA School of Dentistry and Medicine, Los Angeles, USA

Mariela Vasileva-Slaveva

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium

Ute Ganswindt

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria

Ira Skvortsova

Ira.Skvortsova@i-med.ac.at

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
EORTC PathoBiology Group, Brussels, Belgium

Sergej Skvortsov

Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
DOI: https://doi.org/10.2478/raon-2020-0007 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 103 - 118
Submitted on: Jan 10, 2020
|
Accepted on: Jan 30, 2020
|
Published on: Feb 14, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Giulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, Maja Cemazar, Andrej Coer, Gorana Gasljevic, Dragana Savic, Maxim Sorokin, Anton Buzdin, Maurizio Callari, Irma Kvitsaridze, Anahid Jewett, Mariela Vasileva-Slaveva, Ute Ganswindt, Ira Skvortsova, Sergej Skvortsov, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.